|
|
| (113 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| | + | *'''[[Clinical guidelines and advice]]''' |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32353109|t=ä. COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy |pdf=|usr=}}
| |
| − | {{tp|p=32343984|t=ä. COVID-19: before stopping specific infection control measures, be sure to exclude the diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=32201156|t=ä. Multiple parameters required for diagnosis of COVID-19 in clinical practice |pdf=|usr=}}
| |
| − | {{tp|p=32340895|t=ä. Less is More: Intelligent Intensive Care for SARS-CoV-2 Based on the Imaging Data |pdf=|usr=}}
| |
| − | {{tp|p=32327330|t=ä. Management of mild cases of COVID-19 in low-resource countries: An experience in Vietnam |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| | | | |
| − | ----
| + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| − | *'''[[Structure of covid19]]'''
| |
| − | {{tp|p=32320687|t=ä. Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Target binding and uptake]]'''
| |
| | | | |
| | + | |
| | + | *'''[[Structure of covid19]]''' |
| | | | |
| | | | |
| | + | *'''[[Target binding and uptake]]''' |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| − |
| |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=31981224|t=2020. Coronavirus infections and immune responses |pdf=|usr=}}
| |
| − | {{tp|p=32198005|t=2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| | + | *'''[[Pathobiology]]''' |
| | | | |
| | | | |
| − | *'''[[Early symptoms]]''' | + | *'''[[Disease Models]]''' |
| | | | |
| − | *'''[[Systemic disease, any manifestations]]'''
| |
| | | | |
| − | *'''[[Co-Infection]]''' | + | *'''[[Similar diseases and pathomechanisms]]''' |
| − | {{tp|p=32307254|t=ä. Invasive fungal diseases during COVID-19: We should be prepared |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]'''
| |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]'''
| |
| | | | |
| − | *'''[[Microvascular]]''' | + | *'''[[Early symptoms]]''' |
| | | | |
| − | *'''[[Heart]]''' | + | *'''[[Systemic disease, any manifestations]]''' |
| − | {{tp|p=32209382|t=ä. The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32370558|t=2020. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32360703|t=ä. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications |pdf=|usr=}}
| + | |
| − | {{tp|p=32339565|t=ä. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know |pdf=|usr=}}
| + | |
| − | {{tp|p=32289321|t=ä. Cardiovascular molecular mechanisms of disease with COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | {{tp|p=32333166|t=ä. Guillain-Barre syndrome following COVID-19: new infection, old complication?|pdf=|usr=}}
| |
| − | {{tp|p=32354768|t=2020. Characteristics of ischaemic stroke associated with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32299010|t=ä. Neurotropism of SARS-CoV 2: Mechanisms and manifestations |pdf=|usr=}}
| |
| − | {{ttp|p=32299017|t=2020. Central nervous system manifestations of COVID-19: A systematic review |pdf=|usr=}}
| |
| − | {{tp|p=32366299|t=2020. Early recovery following new onset anosmia during the COVID-19 pandemic ? an observational cohort study |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Pulmonary embolism, coagulation]]''' |
| | | | |
| | | | |
| − | *'''[[Dermatology]]'''
| |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32363540|t=ä. Bowel Necrosis in the Setting of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32298767|t=ä. COVID-19: Abnormal liver function tests |pdf=|usr=}}
| |
| − | {{tp|p=32249184|t=ä. Can COVID-19 present unusual GI symptoms?|pdf=|usr=}}
| |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| + | *'''[[Hematology]]''' |
| | | | |
| | | | |
| − | *'''[[Pathobiology]]'''
| |
| | | | |
| | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | ----
| |
| | | | |
| | + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| − | {{tp|p=32031264|t=2020. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring |pdf=|usr=}}
| |
| − | {{ttp|p=31944312|t=2020. Recent advances in the detection of respiratory virus infection in humans |pdf=|usr=}}
| |
| − | {{tp|p=32276051|t=ä. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Dermatology]]''' |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]'''
| |
| − | {{tp|p=32279977|t=ä. What We Know So Far (As of March 26, 2020) About COVID-19 ? An MRT Point of View |pdf=|usr=}}
| |
| − | {{tp|p=32328927|t=2020. (J Med Ultrasound) COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[The morbid survivor]]''' |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Risk and special populations]]''' |
| | | | |
| − | *'''[[Respiration mgmt]]'''
| |
| − | {{tp|p=32340627|t=2020. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Risk and special populations]]''' | + | *'''[[Case reports]]''' |
| − | {{tp|p=32305459|t=2020. Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report |pdf=|usr=}}
| + | |
| − | {{tp|p=32198004|t=ä. A Patient with SARS-CoV-2 Infection during Pregnancy in Qingdao, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32147409|t=ä. Are children less susceptible to COVID-19?|pdf=|usr=}}
| + | |
| − | {{tp|p=32272142|t=ä. More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32366317|t=2020. Covid-19?The real role of NSAIDs in Italy |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]'''
| |
| − | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32222763|t=ä. COVID-19 Through the Lens of Gerontology |pdf=|usr=}}
| |
| − | {{tp|p=32305489|t=ä. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France |pdf=|usr=}}
| |
| | | | |
| | | | |
| − |
| |
| − |
| |
| − | *'''[[Case reports]]'''
| |
| − | {{tp|p=32193905|t=2020. First Pediatric Case of Coronavirus Disease 2019 in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32080990|t=2020. Virus Isolation from the First Patient with SARS-CoV-2 in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32030925|t=2020. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures |pdf=|usr=}}
| |
| − | {{tp|p=32073161|t=2020. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32111449|t=ä. 2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32233161|t=2020. Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32242348|t=2020. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32359943|t=ä. A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32305269|t=ä. Coronavirus-19 Disease (COVID-19): A case series of early suspects reported and the implications towards the response to the pandemic in Zimbabwe |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32307245|t=ä. Treatment options for COVID-19: The reality and challenges |pdf=|usr=}}
| |
| − | {{tp|p=32331982|t=ä. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32236561|t=ä. Combating COVID-19 with Chloroquine |pdf=|usr=}}
| |
| − | {{tp|p=32361836|t=ä. CNS penetration of potential anti-COVID-19 drugs |pdf=|usr=}}
| |
| | | | |
| − |
| |
| − |
| |
| − | ----
| |
| − |
| |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| − | {{tp|p=32303482|t=ä. Re-emergence of SARS-CoV2 in a discharged COVID-19 case |pdf=|usr=}}
| |
| − | {{tp|p=32299784|t=ä. How do we decide to de-isolate COVID-19 patients?|pdf=|usr=}}
| |
| | | | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32276848|t=ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32224116|t=ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| − | {{tp|p=32360356|t=ä. Putting some context to the aerosolization debate around SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Passive protective equipment]]'''
| |
| | | | |
| | | | |
| − | *'''[[Running your hospital]]''' | + | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32305270|t=ä. How to prevent outbreak of a hospital-affiliated dementia day-care facility in the pandemic COVID-19 infection in Taiwan |pdf=|usr=}}
| + | |
| − | {{tp|p=32303483|t=ä. COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored |pdf=|usr=}}
| + | |
| − | {{tp|p=32303480|t=ä. Recommendations for protecting against and mitigating the COVID-19 pandemic in long-term care facilities |pdf=|usr=}}
| + | |
| − | {{tp|p=32251839|t=ä. Perspectives on Surgery in the time of COVID-19: Safety First |pdf=|usr=}}
| + | |
| − | {{tp|p=32247882|t=ä. Understanding the "Scope" of the Problem: Why Laparoscopy is Considered Safe During the COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32247881|t=2020. Surgical Decision Making in the Era of COVID-19: A New Set of Rules |pdf=|usr=}}
| + | |
| − | {{tp|p=32344034|t=ä. How Brazil is dealing with COVID-19 pandemic arrival regarding elective gynecological surgeries |pdf=|usr=}}
| + | |
| − | {{tp|p=32344028|t=ä. APPROACH TO SURGICAL INTERVENTIONS DURING COVID-19 PANDEMIC IN TURKEY |pdf=|usr=}}
| + | |
| − | {{tp|p=32344025|t=ä. Point of view of the Dutch Society for Gynaecological Endoscopy (WGE) on surgery during the COVID-19 crisis |pdf=|usr=}}
| + | |
| − | {{tp|p=32339754|t=ä. COVID-19 pandemic Impact on hysteroscopic procedures A consensus statement from the Global Congress of Hysteroscopy Scientific Committee |pdf=|usr=}}
| + | |
| − | {{tp|p=32334041|t=ä. Guidelines for infection prevention and control in perioperative patients during the COVID-19 pandemic: protocol from a tertiary general hospital in Beijing |pdf=|usr=}}
| + | |
| − | {{tp|p=32294548|t=ä. Minimally Invasive Surgery at the Time of COVID-19: The OR Staff Needs Protection |pdf=|usr=}}
| + | |
| − | {{tp|p=32344993|t=2020. COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson s Disease Patient Care |pdf=|usr=}}
| + | |
| − | {{tp|p=32323202|t=ä. COVID-19 and dialysis: why we should be worried |pdf=|usr=}}
| + | |
| − | {{tp|p=32277423|t=ä. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy |pdf=|usr=}}
| + | |
| − | {{tp|p=32207068|t=ä. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy |pdf=|usr=}}
| + | |
| − | {{tp|p=32200489|t=ä. Hospitals as health factories and the coronavirus epidemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32303837|t=ä. Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32247193|t=ä. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32372178|t=ä. Neurosurgical management of brain and spine tumors in the COVID-19 era: an institutional experience from the epicenter of the pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32274630|t=ä. Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology |pdf=|usr=}}
| + | |
| − | {{tp|p=32285310|t=ä. Milan 2020: COVID-19, neuro-oncology and much more |pdf=|usr=}}
| + | |
| − | {{tp|p=32277379|t=ä. May we deliver neuro-oncology in difficult times (e g COVID-19)?|pdf=|usr=}}
| + | |
| − | {{tp|p=32277378|t=ä. Experiences of practicing surgical neuro-oncology during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32221059|t=2020. Reflections on Nursing Ingenuity During the COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32330900|t=2020. Editorial COVID-19 and neurosurgical practice: an interim report |pdf=|usr=}}
| + | |
| − | {{tp|p=32330899|t=2020. Editorial Impact of COVID-19 on neurosurgery resident research training |pdf=|usr=}}
| + | |
| − | {{tp|p=32330898|t=2020. Editorial Community practice in the time of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32330897|t=2020. Editorial Lessons learned: special precautions for performing emergency cerebrovascular procedures amid the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32302998|t=2020. Editorial Task shifting and task sharing for neurosurgeons amidst the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32302996|t=2020. Editorial Endonasal neurosurgery during the COVID-19 pandemic: the Singapore perspective |pdf=|usr=}}
| + | |
| − | {{tp|p=32302995|t=2020. Editorial Neurosurgical priority setting during a pandemic: COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32302992|t=2020. Editorial COVID-19 and academic neurosurgery |pdf=|usr=}}
| + | |
| − | {{tp|p=32302991|t=2020. Editorial Innovations in neurosurgical education during the COVID-19 pandemic: is it time to reexamine our neurosurgical training models?|pdf=|usr=}}
| + | |
| − | {{tp|p=32302990|t=2020. Editorial Impact of COVID-19 on neurosurgery resident training and education |pdf=|usr=}}
| + | |
| − | {{tp|p=32302993|t=2020. Editorial COVID-19 and its impact on neurosurgery: our early experience in Singapore |pdf=|usr=}}
| + | |
| − | {{tp|p=32302994|t=2020. Editorial A neurosurgery resident?s response to COVID-19: anything but routine |pdf=|usr=}}
| + | |
| − | {{tp|p=C7161162|t=2020. Editorial Neurosurgery in the storm of COVID-19: suggestions from the Lombardy region, Italy (ex malo bonum) |pdf=|usr=}}
| + | |
| − | {{tp|p=C7161163|t=2020. Editorial Response to COVID-19 in Chinese neurosurgery and beyond |pdf=|usr=}}
| + | |
| − | {{tp|p=32302988|t=2020. Editorial Pediatric neurosurgery along with Children s Hospitals innovations are rapid and uniform in response to the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32347685|t=2020. Neurosurgical activity during COVID-19 pandemic: an expert opinion from China, South Korea, Italy, United Stated of America, Colombia and United Kingdom |pdf=|usr=}}
| + | |
| − | {{tp|p=32276256|t=2020. Editorial Early lessons in the management of COVID-19 for the pediatric neurosurgical community from the leadership of the American Society of Pediatric Neurosurgeons |pdf=|usr=}}
| + | |
| − | {{tp|p=C7161161|t=2020. Introduction On pandemics: the impact of COVID-19 on the practice of neurosurgery |pdf=|usr=}}
| + | |
| − | {{tp|p=32347683|t=2020. Neurosurgery at the time of COVID-19: how this pandemic infectious disease is influencing neurosurgical activities and patient management |pdf=|usr=}}
| + | |
| − | {{tp|p=32347682|t=2020. Impact of COVID-19 mitigation measures on patients with spine disease in Friuli Venezia Giulia |pdf=|usr=}}
| + | |
| − | {{tp|p=32347681|t=2020. Impact of COVID-19 pandemic on Subarachnoid Hemorrhage |pdf=|usr=}}
| + | |
| − | {{tp|p=32302989|t=2020. Editorial COVID-19 and spinal surgery |pdf=|usr=}}
| + | |
| − | {{tp|p=32306210|t=ä. Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT) |pdf=|usr=}}
| + | |
| − | {{tp|p=32346694|t=ä. TELE-ICU in the Age of COVID-19: Built for this Challenge |pdf=|usr=}}
| + | |
| − | {{ttp|p=32346683|t=ä. Prevention of COVID-19 in Older Adults: A Brief Guidance from the International Association for Gerontology and Geriatrics (IAGG) Asia/Oceania Region |pdf=|usr=}}
| + | |
| − | {{ttp|p=32346682|t=ä. The New Challenge of Geriatrics: Saving Frail Older People from the SARS-CoV-2 Pandemic Infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32346680|t=ä. A COVID-19 Support Platform for Long Term Care Facilities |pdf=|usr=}}
| + | |
| − | {{tp|p=32346679|t=ä. Geriatric Medicine in Italy in the Time of Covid-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32242202|t=ä. COVID-19 and Older Adult |pdf=|usr=}}
| + | |
| − | {{tp|p=32346677|t=ä. COVID-19 Spiraling of Frailty in Older Italian Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32294453|t=ä. (ObGyn) Current Resources for Evidence-Based Practice, May 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32289259|t=ä. (ObGyn) Reflections on COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32302531|t=ä. The Financial Impact of COVID-19 on Our Practice |pdf=|usr=}}
| + | |
| − | {{tp|p=32302529|t=ä. A Pinch of Prevention is Worth a Pound of Cure: Proactive Dentistry in the Wake of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32372852|t=2020. Orthopaedic patient workflow in CoViD-19 pandemic in Italy |pdf=|usr=}}
| + | |
| − | {{tp|p=32301767|t=ä. The Orthopaedic Trauma Service and COVID-19: Practice Considerations to Optimize Outcomes and Limit Exposure |pdf=|usr=}}
| + | |
| − | {{tp|p=32375884|t=2020. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology ? head and neck surgery during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32304660|t=ä. The Role of Oral and Maxillofacial Surgeons in COVID-19 Response |pdf=|usr=}}
| + | |
| − | {{tp|p=32240755|t=ä. Home Care for Cancer Patients During COVID-19 Pandemic: The Double Triage Protocol |pdf=|usr=}}
| + | |
| − | {{tp|p=32240754|t=ä. Creating a Palliative Care Inpatient Response Plan for COVID-19?The UW Medicine Experience |pdf=|usr=}}
| + | |
| − | {{tp|p=32229286|t=ä. What Should Palliative Care s Response Be to the COVID-19 Pandemic?|pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | | + | *'''[[Running your hospital]]''' |
| − | ----
| + | |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| + | |
| − | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| − | {{tp|p=32346678|t=ä. Loneliness and Social Isolation in Older Adults During the Covid-19 Pandemic: Implications for Gerontological Social Work |pdf=|usr=}}
| |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| − | {{tp|p=32147406|t=ä. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32243947|t=ä. Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278703|t=ä. Preventing the Transmission of COVID-19 Amongst Healthcare Workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278701|t=ä. Knowledge, attitude and practice regarding COVID-19 among health care workers in Henan, China |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − | {{tp|p=32048740|t=2020. Economic impacts of Wuhan 2019?nCoV on China and the world |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 297: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=31967321|t=2020. Cross?species transmission of the newly identified coronavirus 2019?nCoV |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32277970|t=ä. Strategies to trace back the origin of COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Epidemiology]]''' |
| | | | |
| | | | |
| − | *'''[[Epidemiology]]'''
| |
| − | {{tp|p=32331980|t=ä. Coronavirus Disease 2019 (COVID-19) in Kenya: Preparedness, response and transmissibility |pdf=|usr=}}
| |
| − | {{tp|p=32327328|t=ä. Big data integration and analytics to prevent a potential hospital outbreak of COVID-19 in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32331981|t=ä. Continuous temperature monitoring by a wearable device for early detection of febrile events in the SARS-CoV-2 outbreak in Taiwan, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32305271|t=ä. COVID-19 virus outbreak forecasting of registered and recovered cases after sixty day lockdown in Italy: A data driven model approach |pdf=|usr=}}
| |
| − | {{tp|p=32276849|t=ä. Evacuation of quarantine-qualified nationals from Wuhan for COVID-19 outbreak ? Taiwan experience |pdf=|usr=}}
| |
| − | {{tp|p=32302997|t=2020. Editorial COVID-19 outbreak and its countermeasures in the Republic of Korea |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]'''
| |
| − | {{tp|p=32373315|t=ä. The need to improve the laws and regulations relevant to the outbreak of COVID-19: What might be learned from China?|pdf=|usr=}}
| |
| − | {{tp|p=32302966|t=2020. Health Communication Through News Media During the Early Stage of the COVID-19 Outbreak in China: Digital Topic Modeling Approach |pdf=|usr=}}
| |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − | {{tp|p=32277966|t=ä. Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection |pdf=|usr=}}
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| + | *'''[[misc.]]''' |
| − | {{tp|p=32001309|t=2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[misc.]]''' | + | *'''[[Research tools]]''' |
| − | {{tp|p=32277235|t=ä. My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists |pdf=|usr=}}
| + | |
| − | {{tp|p=32229647|t=2020. COVID-19: An Unintended Force for Medical Revolution?|pdf=|usr=}}
| + | |
| − | {{tp|p=32332154|t=2020. Balancing the duty to treat with the duty to family in the context of the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32293580|t=2020. Global Reach of an Online COVID-19 Course in Multiple Languages on OpenWHO in the First Quarter of 2020: Analysis of Platform Use Data |pdf=|usr=}}
| + | |
| − | {{tp|p=32017153|t=2020. Updates on Wuhan 2019 novel coronavirus epidemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32308571|t=2020. The Unprecedented COVID-19 Crisis |pdf=|usr=}}
| + | |
| − | {{tp|p=32292697|t=ä. Chinese herbal Huo-Gu formula for the treatment of steroid-associated osteonecrosis of femoral head: A 14-year�follow-up of convalescent SARS patients |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Research tools]]''' | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| |
| − | *[biomol.com assays cytokines general spectrum]
| |
| − | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| |
| − | *[codexdna.com dna synthesis]
| |
| − | *
| |
| | | | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
